Author

Emad Estemalik

Institution: Cleveland Clinic Lerner College of Medicine

Observed institutions: Dartmouth–Hitchcock Medical Center, Cleveland Clinic, Istituto Neurologico Mediterraneo, Cleveland Clinic Lerner College of Medicine, Michigan Headache and Neurological Institute, Case Western Reserve University

OpenAlex ID: A5030119786

Preventive treatment in migraine and the new US guidelines

2013 · Emad Estemalik, Tepper · Neuropsychiatric Disease and Treatment · 112

Safety and Efficacy of Occipital Nerves Stimulation for the Treatment of Chronic Migraines: Randomized, Double‐blind, Controlled Single‐center Experience

2016 · Nagy A. Mekhail, Emad Estemalik, et al. · Pain Practice · 48

Implementation and Patient Experience of Outpatient Teleneurology

2020 · Lindsay Ross, James Bena, et al. · Telemedicine Journal and e-Health · 26

Long‐Term Outcomes and Clinical Characteristics of Hypnic Headache Syndrome: 40 Patients Series From a Tertiary Referral Center

2016 · Nauman Tariq, Emad Estemalik, et al. · Headache The Journal of Head and Face Pain · 25

Outcomes of microvascular decompression for trigeminal neuralgia with purely venous compression: A systematic review and meta-analysis

2020 · Pranay Soni, Tamia Potter, et al. · Clinical Neurology and Neurosurgery · 22

A Comprehensive Review of the Use of Deep Brain Stimulation ( DBS ) in Treatment of Psychiatric and Headache Disorders

2015 · Murat Altinay, Emad Estemalik, et al. · Headache The Journal of Head and Face Pain · 19

Changes in acute headache medication use and health care resource utilization: Results from a randomized, double-blind, placebo-controlled clinical trial evaluating galcanezumab in adults with treatment-resistant migraine (CONQUER)

2022 · Anna Ambrosini, Emad Estemalik, et al. · Journal of Managed Care & Specialty Pharmacy · 14

Implementation and Patient Experience with Outpatient Subspecialty Teleneurology Visits at a Single Academic Institution Over Four Years (Plen01.004)

2019 · Lindsay Ross, James Bena, et al. · Neurology · 4

Effects of galcanezumab on acute medication use and health care resource utilization in treatment-resistant migraine: results from randomized, double blind, placebo-controlled clinical trial, conquer

2020 · Anna Ambrosini, Emad Estemalik, et al. · Headache Medicine/Revista Headache Medicine · 2

Preventive Treatment of Episodic Migraine

2014 · Cynthia C. Bamford, Emad Estemalik · Springer eBooks · 1

Real-world Improvements in Cognitive Symptoms After Eptinezumab Treatment in Patients in Whom ≥1 Prior Anti-CGRP Preventive Treatment had Failed: 6-month Results for the Ongoing INFUSE Study (P1-15.006)

2026 · Emad Estemalik, Richard Lipton, et al. · Neurology

Real-world Effectiveness of Eptinezumab in Patients in Whom ≥1 Prior Anti-CGRP Preventive Treatment had Failed: 6-month Results for an Ongoing Prospective Study (P10-15.006)

2026 · Emad Estemalik, Stephane Regnier, et al. · Neurology

Patient-reported outcomes from a real-world evidence study in individuals with migraine initiating eptinezumab after ≥1 prior calcitonin gene-related peptide (CGRP)-targeted preventive therapy

2026 · Amaal J. Starling, Stephane A. Regnier, et al. · Cephalalgia Reports

Outcomes of Microvascular Decompression for Trigeminal Neuralgia with Purely Venous Compression: A Systematic Review and Meta-analysis

2021 · Pranay Soni, Tamia Potter, et al. · Journal of Neurological Surgery Part B Skull Base

COVID-19 related headache exquisite response to therapy

2021 · Aarushi Suneja, Emad Estemalik · Headache The Journal of Head and Face Pain

Works count: 15

Citation count: 273

H-index: 7

I10-index: 7